Covered recipient · General Payments record
JIMMY D BAUGH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,164.78
- Reported across 37 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $395.02 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $96.19 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $54.45 | 2 |
| Amgen Inc. | $50.45 | 2 |
| Cleerly, Inc. | $46.42 | 1 |
| GlaxoSmithKline, LLC. | $36.26 | 2 |
| Abbott Laboratories | $35.42 | 2 |
| Novo Nordisk AS | $32.37 | 2 |
| Lilly USA, LLC | $28.65 | 2 |
| SANOFI-AVENTIS U.S. LLC | $14.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $13.93 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125098536 | CMS |
| Abbott Laboratories | $21.49 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125098538 | CMS |
| Amgen Inc. | $17.95 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117199460 | CMS |
| Amgen Inc. | $32.50 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117199462 | CMS |
| Astellas Pharma US Inc | $96.19 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139379318 | CMS |
| Cleerly, Inc. | $46.42 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144710712 | CMS |
| GlaxoSmithKline, LLC. | $19.07 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116617236 | CMS |
| GlaxoSmithKline, LLC. | $17.19 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116661851 | CMS |
| Lilly USA, LLC | $15.12 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135067021 | CMS |
| Lilly USA, LLC | $13.53 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135024042 | CMS |
| Novartis Pharmaceuticals Corporation | $26.29 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086771153 | CMS |
| Novartis Pharmaceuticals Corporation | $28.16 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086771173 | CMS |
| Novo Nordisk Inc | $16.40 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097096005 | CMS |
| Novo Nordisk Inc | $15.97 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096996971 | CMS |
| SANOFI-AVENTIS U.S. LLC | $14.81 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139823057 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.